Phoreus Biotechnology, Inc. — Form D

Phoreus Biotechnology, Inc. of OLATHE, KS, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-26. The offering totals $2.0M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Christopher BrandtDirectorBaltimore, MD
Michael CoeDirectorPerry, KS
Michael CoeExecutive OfficerPerry, KS
Lynn RundleDirectorAbingdon, VA
Bradley HollidayDirectorKansas City, MO
Nathan SinghDirectorSaint Louis, MO
Matthew TomichDirectorSeattle, WA
Matthew TomichPromoterSeattle, WA
Matthew TomichRelated PersonSeattle, WA
Randall ToshDirectorOlathe, KS
Randall ToshExecutive OfficerOlathe, KS
Rajeet PannuDirectorNew York, NY
Rajeet PannuPromoterNew York, NY
Rajeet PannuRelated PersonNew York, NY
Xiomara Sinisterra-HunterDirectorPort Saint Lucie, FL
David SchaeferDirectorClearwater Beach, FL
David SchaeferExecutive OfficerClearwater Beach, FL
David SchaeferPromoterClearwater Beach, FL
David SchaeferRelated PersonClearwater Beach, FL
Bill AshleyDirectorOverland Park, KS
Bill AshleyPromoterOverland Park, KS
Bill AshleyRelated PersonOverland Park, KS
Steve SchramDirectorGoodyear, AZ
Steve SchramPromoterGoodyear, AZ
Steve SchramRelated PersonGoodyear, AZ

Other filings by this issuer (6)

FiledFormOfferingSold
2026-03-13D$421K
2026-03-13D/A$4.4M
2022-05-11D/A$3.0M$1.9M
2019-12-30D/A$1.1M$550K
2019-07-19D/A$1.1M$300K
2018-08-02D$1.0M$50K

More